FilingReader Intelligence

Apeloa Pharmaceutical revenue falls 15% amid share buyback

August 19, 2025 at 10:10 AM UTCBy FilingReader AI

Apeloa Pharmaceutical reported revenue fell 15.31% to 5.44 billion yuan, while net profit declined 9.89% to 563 million yuan in the first half of 2025.

The company cancelled 10.88 million repurchased shares, reducing total share capital to 1.16 billion shares.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

News Alerts

Get instant email alerts when Apeloa Pharmaceutical publishes news

Free account required • Unsubscribe anytime

Filing Activity Timeline

View Complete Filing History →